Keywords: Grifols, Talecris, CSL, Plasma protein therapies

Spain’s Grifols to pay $3.4 billion for Talecris Bio to create a world leader in plasma protein therapies

Article | 07 June 2010

Spanish health care company Grifols says it has signed a definitive agreement to acquire USA-based Talecris Biotherapeutics for around $3.4 billion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Talecris

Grifols

CSL Limited

Go to company listing